Investigation of the effect of diphencypron on treatment of acute urban leishmaniasis with intralesional injection of glucantime
Phase 2
Recruiting
- Conditions
- Cutaneous leishmaniasis.Cutaneous leishmaniasis
- Registration Number
- IRCT20140414017271N6
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Positive smear or biopsy of the lesion in terms of Leishman body
Lesion in limbs
dry leishmaniasis
The patient has an indication of topical treatment based on the judgment of the therapist and the national protocol for leishmania
A maximum of 6 months has elapsed since the onset of the lesion
The patient has an informed consent to participate in the study.
Exclusion Criteria
Sensitivity to intralesional injection of glucantime
The presence of secondary infection in the lesion based on the researcher's judgment
Pregnancy or breastfeeding
Wet leishmaniasis, Lupoid, Sporotricoid
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of recovery in the two groups. Timepoint: Every week after the injection up to 12 weeks. Method of measurement: Size of the lesions will be recorded using a ruler and stiffness and induration will also be recorded based on examination in each session.;The amount of time needed for the lesions to heal. Timepoint: Every week until lesion recovery. Method of measurement: Based on the number of weeks passed until recovery.
- Secondary Outcome Measures
Name Time Method